191 related articles for article (PubMed ID: 29061769)
21. Therapeutic strategies for the treatment of neuroblastoma.
Izbicka E; Izbicki T
Curr Opin Investig Drugs; 2005 Dec; 6(12):1200-14. PubMed ID: 16370386
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma: Therapeutic strategies for a clinical enigma.
Modak S; Cheung NK
Cancer Treat Rev; 2010 Jun; 36(4):307-17. PubMed ID: 20227189
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in cell-based immune therapy for neuroblastoma.
Verneris MR; Wagner JE
J Neuroimmune Pharmacol; 2007 Jun; 2(2):134-9. PubMed ID: 18040838
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic management of high-risk neuroblastoma in children.
Ganeshan VR; Schor NF
Paediatr Drugs; 2011 Aug; 13(4):245-55. PubMed ID: 21692548
[TBL] [Abstract][Full Text] [Related]
25. CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma.
Miles SA; Sandler AD
Adv Drug Deliv Rev; 2009 Mar; 61(3):275-82. PubMed ID: 19186194
[TBL] [Abstract][Full Text] [Related]
26. Aiming at neuroblastoma and hitting other worthy targets.
Schor NF
J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
[TBL] [Abstract][Full Text] [Related]
27. Anti-angiogenesis in neuroblastoma.
Ribatti D
Crit Rev Oncol Hematol; 2013 Jun; 86(3):212-21. PubMed ID: 23273512
[TBL] [Abstract][Full Text] [Related]
28. Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.
Amoroso L; Haupt R; Garaventa A; Ponzoni M
Expert Opin Investig Drugs; 2017 Nov; 26(11):1281-1293. PubMed ID: 28906153
[TBL] [Abstract][Full Text] [Related]
29. Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.
Nishio N; Fujita M; Tanaka Y; Maki H; Zhang R; Hirosawa T; Demachi-Okamura A; Uemura Y; Taguchi O; Takahashi Y; Kojima S; Kuzushima K
J Immunother; 2012 Oct; 35(8):598-606. PubMed ID: 22996365
[TBL] [Abstract][Full Text] [Related]
30. Antibody-based immunotherapy in high-risk neuroblastoma.
Johnson E; Dean SM; Sondel PM
Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
[TBL] [Abstract][Full Text] [Related]
31. Targets and Antibody Formats for Immunotherapy of Neuroblastoma.
Park JA; Cheung NV
J Clin Oncol; 2020 Jun; 38(16):1836-1848. PubMed ID: 32167865
[TBL] [Abstract][Full Text] [Related]
32. Children's Oncology Group's 2013 blueprint for research: neuroblastoma.
Park JR; Bagatell R; London WB; Maris JM; Cohn SL; Mattay KK; Hogarty M;
Pediatr Blood Cancer; 2013 Jun; 60(6):985-93. PubMed ID: 23255319
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in neuroblastoma.
Bowen KA; Chung DH
Curr Opin Pediatr; 2009 Jun; 21(3):350-6. PubMed ID: 19381091
[TBL] [Abstract][Full Text] [Related]
34. Expression of Truncated Neurokinin-1 Receptor in Childhood Neuroblastoma is Independent of Tumor Biology and Stage.
Pohl A; Kappler R; Mühling J; VON Schweinitz D; Berger M
Anticancer Res; 2017 Nov; 37(11):6079-6085. PubMed ID: 29061788
[TBL] [Abstract][Full Text] [Related]
35. Overview and recent advances in the treatment of neuroblastoma.
Whittle SB; Smith V; Doherty E; Zhao S; McCarty S; Zage PE
Expert Rev Anticancer Ther; 2017 Apr; 17(4):369-386. PubMed ID: 28142287
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
37. Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.
Morandi F; Frassoni F; Ponzoni M; Brignole C
J Immunol Res; 2018; 2018():8097398. PubMed ID: 30510968
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Hematol Oncol Clin North Am; 2010 Feb; 24(1):65-86. PubMed ID: 20113896
[TBL] [Abstract][Full Text] [Related]
40. NFκB and MHC-1 Interplay in Neuroblastoma and Immunotherapy.
Spel L; Schiepers A; Boes M
Trends Cancer; 2018 Nov; 4(11):715-717. PubMed ID: 30352674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
